Morphologic and functional changes in the unilateral 6-hydroxydopamine lesion rat model for Parkinson's disease discerned with μsPECT and quantitative MRI

Magnetic Resonance Materials in Physics, Biology and Medicine

Volumn 23, Issue 2, 2010, Pages 65-75

  Van Camp, Nadja ^a   Vreys, Ruth ^a   Van Laere, Koen ^b   Lauwers, Erwin ^c   Beque, Dirk ^b   Verhoye, Marleen ^a   Casteels, Cindy ^b   Verbruggen, Alfons ^d   Debyser, Zeger ^e   Mortelmans, Luc ^b   Sijbers, Jan ^a   Nuyts, Johan ^b   Baekelandt, Veerle ^c   Van Der Linden, Annemie ^a  

^a UNIVERSITY OF ANTWERP   (Belgium)

^b UNIVERSITY HOSPITALS LEUVEN   (Belgium)

^c Laboratory for Molecular Virology and Gene Therapy   (Belgium)

^d UNIVERSITY OF LEUVEN   (Belgium)

^e DEPARTMENT OF PHARMACEUTICAL AND PHARMACOLOGICAL SCIENCES   (Belgium)

Author keywords

MRI; Neurodegeneration; Parkinson's disease; Rat; SPECT

Indexed keywords

OXIDOPAMINE;

ANIMAL; ARTICLE; CHEMICALLY INDUCED DISORDER; COMPARATIVE STUDY; CORPUS STRIATUM; DISEASE MODEL; EVALUATION; FEMALE; METHODOLOGY; NUCLEAR MAGNETIC RESONANCE IMAGING; PARKINSONISM; PATHOLOGY; POSITRON EMISSION TOMOGRAPHY; RADIOGRAPHY; RAT; REPRODUCIBILITY; SENSITIVITY AND SPECIFICITY; WISTAR RAT;

ANIMALS; CORPUS STRIATUM; DISEASE MODELS, ANIMAL; FEMALE; MAGNETIC RESONANCE IMAGING; OXIDOPAMINE; PARKINSONIAN DISORDERS; POSITRON-EMISSION TOMOGRAPHY; RATS; RATS, WISTAR; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY;

ANIMALIA; RATTUS; RODENTIA;

EID: 77952423316     PISSN: 09685243     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10334-010-0198-7     Document Type: Article

References (46)

1. RS Burns CC Chiueh SP Markey MH Ebert DM Jacobowitz IJ Kopin 1983 A primate model of parkinsonism: selective destruction of dopaminergic neurons in the pars compacta of the substantia nigra by N-methyl-4-phenyl-1,2,3,6- tetrahydropyridine Proc Natl Acad Sci USA 80 14 4546 4550 10.1073/pnas.80.14. 4546 1:CAS:528:DyaL3sXkvVKisr8%3D 6192438
2. JS Mendez BW Finn 1975 Use of 6-hydroxydopamine to create lesions in catecholamine neurons in rats J Neurosurg 42 2 166 173 10.3171/jns.1975.42.2. 0166 1:CAS:528:DyaE2MXktVWnu7s%3D 234524
3. R Schwarting J Huston 1996 Unilateral 6-hydroxydopamine lesions of meso-striatal dopamine neurons and their physiological sequelae Prog Neurobiol 49 3 215 266 10.1016/S0301-0082(96)00015-9 1:CAS:528:DyaK28XlvFKrt74%3D 8878304 (Pubitemid 26276331)
4. Y Huang L Cheung D Rowe G Halliday 2004 Genetic contributions to Parkinson's disease Brain Res Brain Res Rev 46 1 44 70 10.1016/j.brainresrev. 2004.04.007 1:CAS:528:DC%2BD2cXmsVGit7k%3D 15297154 (Pubitemid 39030771)
5. E Lauwers D Beque K Van Laere J Nuyts G Bormans L Mortelmans C Casteels L Vercammen O Bockstael B Nuttin Z Debyser V Baekelandt 2006 Non-invasive imaging of neuropathology in a rat model of alpha-synuclein overexpression Neurobiol Aging 28 2 248 257 10.1016/j.neurobiolaging.2005.12.005 16423428
6. E Lauwers Z Debyser J Van Dorpe B De Strooper B Nuttin V Baekelandt 2003 Neuropathology and neurodegeneration in rodent brain induced by lentiviral vector-mediated overexpression of alpha-synuclein Brain Pathol 13 3 364 372 1:CAS:528:DC%2BD3sXntVCntbo%3D 12946025
7. V Baekelandt A Claeys K Eggermont E Lauwers B De Strooper B Nuttin Z Debyser 2002 Characterization of lentiviral vector-mediated gene transfer in adult mouse brain Hum Gene Ther 13 7 841 853 10.1089/10430340252899019 1:CAS:528:DC%2BD38XjsFaktbg%3D 11975850 (Pubitemid 34493977)
8. BC Lo BL Schneider M Bauer A Sajadi A Brice T Iwatsubo P Aebischer 2004 Lentiviral vector delivery of parkin prevents dopaminergic degeneration in an alpha-synuclein rat model of Parkinson's disease Proc Natl Acad Sci USA 101 50 17510 17515 10.1073/pnas.0408242101 (Pubitemid 39657440)
9. BC Lo JL Ridet BL Schneider N Deglon P Aebischer 2002 alpha-Synucleinopathy and selective dopaminergic neuron loss in a rat lentiviral-based model of Parkinson's disease Proc Natl Acad Sci USA 99 16 10813 10818 10.1073/pnas.152339799
10. MD Boska KM Hasan D Kibuule R Banerjee E McIntyre JA Nelson T Hahn HE Gendelman RL Mosley 2007 Quantitative diffusion tensor imaging detects dopaminergic neuronal degeneration in a murine model of Parkinson's disease Neurobiol Dis 26 3 590 596 10.1016/j.nbd.2007.02.010 1:CAS:528: DC%2BD2sXlsFKnsbw%3D 17428671 (Pubitemid 46756326)
11. T Kondoh M Bannai H Nishino K Torii 2005 6-Hydroxydopamine-induced lesions in a rat model of hemi-Parkinson's disease monitored by magnetic resonance imaging Exp Neurol 192 1 194 202 10.1016/j.expneurol.2004.12.016 1:CAS:528:DC%2BD2MXhtVKgs7w%3D 15698634 (Pubitemid 40208553)
12. G Pelled H Bergman G Goelman 2002 Bilateral overactivation of the sensorimotor cortex in the unilateral rodent model of Parkinson's disease-a functional magnetic resonance imaging study Eur J Neurosci 15 2 389 394 10.1046/j.0953-816x.2001.01866.x 11849305 (Pubitemid 35471960)
13. G Pelled H Bergman T Ben-Hur G Goelman 2005 Reduced basal activity and increased functional homogeneity in sensorimotor and striatum of a Parkinson's disease rat model: a functional MRI study Eur J Neurosci 21 8 2227 2232 10.1111/j.1460-9568.2005.04035.x 15869519 (Pubitemid 40695247)
14. G Pelled H Bergman T Ben-Hur G Goelman 2007 Manganese-enhanced MRI in a rat model of Parkinson's disease J Magn Reson Imaging 26 4 863 870 10.1002/jmri.21051 17896372 (Pubitemid 47548144)
15. R Schwarting J Huston 1996 The unilateral 6-hydroxydopamine lesion model in behavioral brain research. Analysis of functional deficits, recovery and treatments Prog Neurobiol 50 2-3 275 331 10.1016/S0301-0082(96)00040-8 1:CAS:528:DyaK2sXks12hsQ%3D%3D 8971983 (Pubitemid 26412599)
16. AJ Fischman JW Babich DR Elmaleh SA Barrow P Meltzer RN Hanson BK Madras 1997 SPECT imaging of dopamine transporter sites in normal and MPTP-treated rhesus monkeys J Nucl Med 38 1 144 150 1:CAS:528:DyaK2sXotlemuw%3D%3D 8998169
17. J Booij G Andringa LJ Rijks RJ Vermeulen K De Bruin GJ Boer AG Janssen EA Van Royen 1997 123I]FP-CIT binds to the dopamine transporter as assessed by biodistribution studies in rats and SPECT studies in MPTP-lesioned monkeys Synapse 27 3 183 190 10.1002/(SICI)1098-2396(199711)27:3<183::AID-SYN4>3. 0.CO;2-9 1:CAS:528:DyaK2sXmsFekt7c%3D 9329154 (Pubitemid 27430668)
18. C Scherfler E Donnemiller M Schocke K Dierkes C Decristoforo M Oberladstatter C Kolbitsch F Zschiegner G Riccabona W Poewe 2002 Evaluation of striatal dopamine transporter function in rats by in vivo beta-[123I]CIT pinhole SPECT NeuroImage 17 1 128 141 10.1006/nimg.2002.1158 12482072
19. W Meissner C Prunier D Guilloteau S Chalon CE Gross E Bezard 2003 Time-course of nigrostriatal degeneration in a progressive MPTP-lesioned macaque model of Parkinson's disease Mol Neurobiol 28 3 209 218 10.1385/MN:28:3:209 1:CAS:528:DC%2BD2cXitlemug%3D%3D 14709785 (Pubitemid 38156419)
20. DA Perese J Ulman J Viola SE Ewing KS Bankiewicz 1989 A 6-hydroxydopamine-induced selective parkinsonian rat model Brain Res 494 2 285 293 10.1016/0006-8993(89)90597-0 1:CAS:528:DyaL1MXlsFWnt7w%3D 2528389 (Pubitemid 19194542)
21. J Thomas J Wang H Takubo J Sheng S de Jesus KS Bankiewicz 1994 A 6-hydroxydopamine-induced selective Parkinsonian rat model: further biochemical and behavioral characterization Exp Neurol 126 2 159 167 10.1006/exnr.1994.1054 1:CAS:528:DyaK2cXltVGqsrY%3D 7925817
22. DA Perese J Ulman J Viola SE Ewing KS Bankiewicz 1989 A 6-hydroxydopamine-induced selective parkinsonian rat model Brain Res 494 2 285 293 10.1016/0006-8993(89)90597-0 1:CAS:528:DyaL1MXlsFWnt7w%3D 2528389 (Pubitemid 19194542)
23. U Ungerstedt 1971 Striatal dopamine release after amphetamine or nerve degeneration revealed by rotational behaviour Acta Physiol Scand 367 49 68 1:STN:280:DyaE38%2FovVChtQ%3D%3D
24. J Votaw M Byas-Smith J Hua R Voll L Martarello AI Levey FD Bowman M Goodman 2003 Interaction of isoflurane with the dopamine transporter Anesthesiology 98 2 404 411 10.1097/00000542-200302000-00021 1:CAS:528:DC%2BD3sXmsFCltg%3D%3D 12552200 (Pubitemid 36592809)
25. JR Votaw MG Byas-Smith R Voll R Halkar MM Goodman 2004 Isoflurane alters the amount of dopamine transporter expressed on the plasma membrane in humans Anesthesiology 101 5 1128 1135 10.1097/00000542-200411000-00012 1:CAS:528:DC%2BD2cXovVGhsrk%3D 15505448 (Pubitemid 39430792)
26. Bequé D, Vanhove C, Andreyev A, Nuyts J, Defrise M (2004) Correction for imperfect camera motion and resolution recovery in pinhole SPECT. Conference proceedings of IEEE medical imaging conference, Rome, Italy M2-173
27. D Bequé J Nuyts P Suetens P Bormans 2005 Optimization of geometrical calibration in pinhole SPECT IEEE Trans Med Imaging 24 5 667 675 10.1109/TMI.2005.846850 15889553 (Pubitemid 40680127)
28. C Casteels P Vermaelen J Nuyts LA Van Der V Baekelandt L Mortelmans G Bormans LK Van 2006 Construction and evaluation of multitracer small-animal PET probabilistic atlases for voxel-based functional mapping of the rat brain J Nucl Med 47 11 1858 1866 17079820
29. S Hall JN Rutledge T Schallert 1992 MRI, brain iron and experimental Parkinson's disease J Neurol Sci 113 2 198 1208 10.1016/0022-510X(92)90247-I 1:CAS:528:DyaK3sXhsVCqu7w%3D 1487755 (Pubitemid 23000567)
30. T Kondoh M Bannai H Nishino K Torii 2005 6-Hydroxydopamine-induced lesions in a rat model of hemi-Parkinson's disease monitored by magnetic resonance imaging Exp Neurol 192 1 194 202 10.1016/j.expneurol.2004.12.016 1:CAS:528:DC%2BD2MXhtVKgs7w%3D 15698634 (Pubitemid 40208553)
31. C Casteels E Lauwers G Bormans V Baekelandt LK Van 2008 Metabolic-dopaminergic mapping of the 6-hydroxydopamine rat model for Parkinson's disease Eur J Nucl Med Mol Imaging 35 1 124 134 10.1007/s00259-007- 0558-3 1:CAS:528:DC%2BD2sXhsVSmtLbJ 17906859 (Pubitemid 350234144)
32. DM Araujo SR Cherry KJ Tatsukawa T Toyokuni HI Kornblum 2000 Deficits in striatal dopamine D(2) receptors and energy metabolism detected by in vivo microPET imaging in a rat model of Huntington's disease Exp Neurol 166 2 287 297 10.1006/exnr.2000.7514 1:CAS:528:DC%2BD3cXotFCrsLg%3D 11085894
33. J Booij K de Bruin MML de Win C Lavini GJ den Heeten JBA Habraken 2003 Imaging of striatal dopamine transporters in rat brain with single pinhole SPECT and co-aligned MRI is highly reproducible Nucl Med Biol 30 6 643 649 10.1016/S0969-8051(03)00046-5 1:CAS:528:DC%2BD3sXlvFyntr4%3D 12900290 (Pubitemid 37289326)
34. K Baete J Nuyts KV Laere W Van Paesschen S Ceyssens L De Ceuninck O Gheysens A Kelles J Vanden Eynden P Suetens P Dupont 2004 Evaluation of anatomy based reconstruction for partial volume correction in brain FDG-PET NeuroImage 23 1 305 317 10.1016/j.neuroimage.2004.04.041 15325378 (Pubitemid 39119461)
35. P Kosta MI Argyropoulou S Markoula S Konitsiotis 2006 MRI evaluation of the basal ganglia size and iron content in patients with Parkinson's disease J Neurol 253 1 26 32 10.1007/s00415-005-0914-9 15981079 (Pubitemid 43157384)
36. J Vymazal A Righini R Brooks M Canesi C Mariani M Leonardi G Pezzoli 1999 T1 and T2 in the brain of healthy subjects, patients with Parkinson disease, and patients with multiple system atrophy: relation to iron content Radiology 211 2 489 495 1:STN:280:DyaK1M3ksFaitQ%3D%3D 10228533
37. F Ye P Allen W Martin 1996 Basal ganglia iron content in Parkinson's disease measured with magnetic resonance Mov Disord 11 3 243 249 10.1002/mds.870110305 1:STN:280:DyaK28zgtVCrug%3D%3D 8723139 (Pubitemid 26138821)
38. PA Brex GJ Parker SM Leary PD Molyneux GJ Barker CA Davie AJ Thompson DH Miller 2000 Lesion heterogeneity in multiple sclerosis: a study of the relations between appearances on T1 weighted images, T1 relaxation times, and metabolite concentrations J Neurol Neurosurg Psychiatry 68 5 627 632 10.1136/jnnp.68.5.627 1:STN:280:DC%2BD3c3ivF2htg%3D%3D 10766895 (Pubitemid 30248830)
39. Paxinos G (1995) The rat nervous system. 2 edn. Academic Press, California
40. JL Hsu TP Jung CY Hsu WC Hsu YK Chen JR Duann HC Wang S Makeig 2007 Regional CBF changes in Parkinson's disease: a correlation with motor dysfunction Eur J Nucl Med Mol Imaging 34 9 1458 1466 10.1007/s00259-006-0360-7 17437108 (Pubitemid 47312576)
41. J Yang TR Sadler TK Givrad JM Maarek DP Holschneider 2007 Changes in brain functional activation during resting and locomotor states after unilateral nigrostriatal damage in rats NeuroImage 36 3 755 773 10.1016/j.neuroimage.2007. 03.010 1:CAS:528:DC%2BD1cXhtlCltLrI 17481921 (Pubitemid 46907632)
42. E Bezard CE Gross JM Brotchie 2003 Presymptomatic compensation in Parkinson's disease is not dopamine-mediated Trends Neurosci 26 4 215 221 10.1016/S0166-2236(03)00038-9 1:CAS:528:DC%2BD3sXis12nsbw%3D 12689773 (Pubitemid 36412004)
43. N Dahlgren O Lindvall A Nobin U Stenevi 1981 Cerebral circulatory response to hypercapnia: effects of lesions of central dopaminergic and serotoninergic neuron systems Brain Res 230 1-2 221 233 10.1016/0006-8993(81) 90403-0 1:STN:280:DyaL38%2Fpt1ygsA%3D%3D 6797677
44. O Lindvall M Ingvar U Stenevi 1981 Effects of methamphetamine on blood flow in the caudate-putamen after lesions of the nigrostriatal dopaminergic bundle in the rat Brain Res 211 1 211 216 10.1016/0006-8993(81)90086-X 1:CAS:528:DyaL3MXhvVGmu70%3D 7225839 (Pubitemid 11147230)
45. S Mraovitch Y Calando B Onteniente M Peschanski J Seylaz 1993 Cerebrovascular and metabolic uncoupling in the caudate-putamen following unilateral lesion of the mesencephalic dopaminergic neurons in the rat Neurosci Lett 157 2 140 144 10.1016/0304-3940(93)90722-W 1:CAS:528:DyaK3sXmsVOiur0%3D 8233044 (Pubitemid 23245514)
46. JK Choi YI Chen E Hamel BG Jenkins 2006 Brain hemodynamic changes mediated by dopamine receptors: Role of the cerebral microvasculature in dopamine-mediated neurovascular coupling NeuroImage 30 3 700 712 10.1016/j.neuroimage.2005.10.029 16459104